Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in countless
infections and caused millions of deaths since its emergence in 2019. Coronavirus disease …

Application of materials capable of energy harvesting to increase the efficiency and
environmental adaptability is sometimes reflected in the ability of discovery of some traces in …

Many drugs are being administered to tackle coronavirus disease 2019 (COVID-19)
pandemic situations without establishing clinical effectiveness or tailoring safety. A …

The landscape of medical treatments is undergoing a transformative shift. Precision
medicine has ushered in a revolutionary era in healthcare by individualizing diagnostics and …

COVID-19 has rapidly become a pandemic worldwide, causing extensive and long-term
health issues. There is an urgent need to identify therapies that limit SARS-CoV-2 infection …

The coronavirus disease (COVID-19) pandemic is a leading global health and economic
challenge. What defines the disease's progression is not entirely understood, but there are …

The use of immune suppressive drugs combined with the natural immune suppression
caused by SARS-CoV-2 can lead to a surge of secondary bacterial and fungal infections …

The major human liver drug metabolising cytochrome P450 (CYP) enzymes are
downregulated during inflammation and infectious disease state, especially during …

A cytokine storm is one of the leading causes of acute respiratory distress syndrome (ARDS)
and sepsis‐associated multiple organ failure in many respiratory viral infections, including …

Abstract Remdesivir (RDV, Veklury®) is an FDA-approved prodrug for the treatment of
hospitalized patients with COVID-19. Recent in vitro studies have indicated that human …